These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 28422567)

  • 1. Evaluation of serotypes 5 and 8 capsular polysaccharides in protection against Staphylococcus aureus in murine models of infection.
    Cheng BL; Nielsen TB; Pantapalangkoor P; Zhao F; Lee JC; Montgomery CP; Luna B; Spellberg B; Daum RS
    Hum Vaccin Immunother; 2017 Jul; 13(7):1609-1614. PubMed ID: 28422567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies to Staphylococcus aureus serotype 8 capsular polysaccharide react with and protect against serotype 5 and 8 isolates.
    Park S; Gerber S; Lee JC
    Infect Immun; 2014 Dec; 82(12):5049-55. PubMed ID: 25245803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein antigens increase the protective efficacy of a capsule-based vaccine against Staphylococcus aureus in a rat model of osteomyelitis.
    Lattar SM; Noto Llana M; Denoël P; Germain S; Buzzola FR; Lee JC; Sordelli DO
    Infect Immun; 2014 Jan; 82(1):83-91. PubMed ID: 24126523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SA4Ag, a 4-antigen Staphylococcus aureus vaccine, rapidly induces high levels of bacteria-killing antibodies.
    Begier E; Seiden DJ; Patton M; Zito E; Severs J; Cooper D; Eiden J; Gruber WC; Jansen KU; Anderson AS; Gurtman A
    Vaccine; 2017 Feb; 35(8):1132-1139. PubMed ID: 28143674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to Staphylococcus aureus capsular polysaccharides 5 and 8 perform similarly in vitro but are functionally distinct in vivo.
    Liu B; Park S; Thompson CD; Li X; Lee JC
    Virulence; 2017 Aug; 8(6):859-874. PubMed ID: 27936346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety, tolerability, and immunogenicity of a single dose 4-antigen or 3-antigen Staphylococcus aureus vaccine in healthy older adults: Results of a randomised trial.
    Creech CB; Frenck RW; Sheldon EA; Seiden DJ; Kankam MK; Zito ET; Girgenti D; Severs JM; Immermann FW; McNeil LK; Cooper D; Jansen KU; Gruber W; Eiden J; Anderson AS; Baber J
    Vaccine; 2017 Jan; 35(2):385-394. PubMed ID: 27866765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody-mediated protection against Staphylococcus aureus dermonecrosis and sepsis by a whole cell vaccine.
    Zhang F; Jun M; Ledue O; Herd M; Malley R; Lu YJ
    Vaccine; 2017 Jul; 35(31):3834-3843. PubMed ID: 28601365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. O-Acetylation is essential for functional antibody generation against Staphylococcus aureus capsular polysaccharide.
    Scully IL; Pavliak V; Timofeyeva Y; Liu Y; Singer C; Anderson AS
    Hum Vaccin Immunother; 2018 Jan; 14(1):81-84. PubMed ID: 29182428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical Efficacy of Clumping Factor A in Prevention of Staphylococcus aureus Infection.
    Li X; Wang X; Thompson CD; Park S; Park WB; Lee JC
    mBio; 2016 Feb; 7(1):e02232-15. PubMed ID: 26838725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of genetically inactivated alpha toxin for protection in multiple mouse models of Staphylococcus aureus infection.
    Brady RA; Mocca CP; Prabhakara R; Plaut RD; Shirtliff ME; Merkel TJ; Burns DL
    PLoS One; 2013; 8(4):e63040. PubMed ID: 23658662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural antibodies in normal human serum inhibit Staphylococcus aureus capsular polysaccharide vaccine efficacy.
    Skurnik D; Kropec A; Roux D; Theilacker C; Huebner J; Pier GB
    Clin Infect Dis; 2012 Nov; 55(9):1188-97. PubMed ID: 22806596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy profile of a bivalent Staphylococcus aureus glycoconjugated vaccine in adults on hemodialysis: Phase III randomized study.
    Fattom A; Matalon A; Buerkert J; Taylor K; Damaso S; Boutriau D
    Hum Vaccin Immunother; 2015; 11(3):632-41. PubMed ID: 25483694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination as infection control: a pilot study to determine the impact of Staphylococcus aureus vaccination on nasal carriage.
    Creech CB; Johnson BG; Alsentzer AR; Hohenboken M; Edwards KM; Talbot TR
    Vaccine; 2009 Dec; 28(1):256-60. PubMed ID: 19799842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis.
    Shinefield H; Black S; Fattom A; Horwith G; Rasgon S; Ordonez J; Yeoh H; Law D; Robbins JB; Schneerson R; Muenz L; Fuller S; Johnson J; Fireman B; Alcorn H; Naso R
    N Engl J Med; 2002 Feb; 346(7):491-6. PubMed ID: 11844850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Staphylococcus aureus capsular polysaccharide (CP) vaccine and CP-specific antibodies protect mice against bacterial challenge.
    Fattom AI; Sarwar J; Ortiz A; Naso R
    Infect Immun; 1996 May; 64(5):1659-65. PubMed ID: 8613375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccines targeting Staphylococcus aureus skin and bloodstream infections require different composition.
    Luna BM; Nielsen TB; Cheng B; Pantapalangkoor P; Yan J; Boyle-Vavra S; Bruhn KW; Montgomery C; Spellberg B; Daum R
    PLoS One; 2019; 14(6):e0217439. PubMed ID: 31181086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized phase I study of the safety and immunogenicity of three ascending dose levels of a 3-antigen Staphylococcus aureus vaccine (SA3Ag) in healthy adults.
    Nissen M; Marshall H; Richmond P; Shakib S; Jiang Q; Cooper D; Rill D; Baber J; Eiden J; Gruber W; Jansen KU; Emini EA; Anderson AS; Zito ET; Girgenti D
    Vaccine; 2015 Apr; 33(15):1846-54. PubMed ID: 25707693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against Staphylococcus aureus Colonization and Infection by B- and T-Cell-Mediated Mechanisms.
    Zhang F; Ledue O; Jun M; Goulart C; Malley R; Lu YJ
    mBio; 2018 Oct; 9(5):. PubMed ID: 30327437
    [No Abstract]   [Full Text] [Related]  

  • 19. Development and evaluation of vaccine against Staphylococcus aureus recovered from naturally occurring mastitis in she-camels.
    Aqib AI; Anjum AA; Ijaz M; Hussain R; Ahmed R; Farooqi SH; Aslam HB; Hussain K; Mehmood K; Zhang H
    Microb Pathog; 2018 Apr; 117():341-347. PubMed ID: 29510207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and characterization of a Staphylococcus aureus capsular polysaccharide-protein conjugate prepared by a low cost technique: a proof-of-concept study.
    Pujato N; Díaz G; Barbagelata MS; Vicco MH; Calvinho LF; Marcipar IS
    Appl Biochem Biotechnol; 2015 Jan; 175(1):141-54. PubMed ID: 25245681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.